Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Completed 45Unknown 16Not yet recruiting 5Terminated 4Withdrawn 3Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pain 2Pain, Postoperative 1Neoplasms 1Kidney Neoplasms 1Feeding and Eating Disorders 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Interventional × Ropivacaine × Clear all
NCT04085237 2026-06-04

ESPB

McMaster University

Phase NA Terminated
10 enrolled
Genitourinary

Kidney Neoplasms, Pain, Postoperative

NCT02525211 2026-04-21

Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment

Institut Paoli-Calmettes

Phase 3 Terminated
59 enrolled
Breast

Breast Neoplasms

NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated
17 enrolled

Feeding and Eating Disorders, Neoplasms, Pain

NCT01318161 2021-02-16

EPICOL

Örebro University, Sweden

Phase 3 Terminated
221 enrolled
Gastrointestinal

Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡